Homology Medicines

$9.60
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

$0.00 (0.00%) Today
$0.00 (0.00%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell FIXX and other stocks, options, and ETFs commission-free!

About FIXX

Homology Medicines, Inc. operates as a technology platform to design and develop treatments to address rare diseases at the genetic level. It develops genetic medicines by translating proprietary, next generation gene editing and gene therapy technologies into novel treatments for patients with rare diseases. The company was founded by Saswati Chatterjee in 2015 and is headquartered in Bedford, MA. The listed name for FIXX is Homology Medicines, Inc. Common Stock.

CEO
Arthur O. Tzianabos
Employees
187
Headquarters
Bedford, Massachusetts
Founded
2015
Market Cap
434.54M
Price-Earnings Ratio
Dividend Yield
Average Volume
392.00K
High Today
$9.68
Low Today
$9.53
Open Price
$9.61
Volume
235.35K
52 Week High
$22.50
52 Week Low
$9.19

Collections

FIXX Earnings

-$0.78
-$0.52
-$0.26
$0.00
Q1 FY19
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
per share
Actual
Expected Mar 11, After Hours

You May Also Like